venBio Global Strategic Fund III, L.P. 13D and 13G filings for CinCor Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-26 4:18 pm Sale | 2022-01-11 | 13G | CinCor Pharma, Inc. CINC | venBio Global Strategic Fund III, L.P. | 1,862,256 4.900% | -118,450 (-5.98%) | Filing |
| 2022-01-11 4:46 pm Purchase | 2022-01-11 | 13G | CinCor Pharma, Inc. CINC | venBio Global Strategic Fund III, L.P. | 1,980,706 5.600% | 1,980,706 (New Position) | Filing |